Transcatheter closure for postinfarction ventricular septal defect: A meta ‐analysis of the current evidence
ConclusionTCC should be a relatively safe and minimally invasive method for PIVSD, with an excellent successful device implantation rate and acceptable low 30-day mortality. The procedure appears promising, but its safety and efficacy could only be demonstrated by randomized controlled trials. Therefore, the mortality of data comparing surgery to TCC compels the need for future comparative trials.
Source: Journal of Cardiac Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Xiang Yang,
Zeran Yu,
Yu Wang,
Yunchuan Ding,
Ruizhi Ni,
Pingxi Xiao Tags: ORIGINAL ARTICLE Source Type: research